Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT03933787

Neuropeptide Y and Sympathovagal Balance (NPY)

Neuropeptide Y Function in the Sympathovagal Balance During an Ergometric Test in Healthy Volunteers

Sponsor: Eric Grouzmann

Conditions Physical Activity Secretion; Catecholamine Sympathetic Nervous System

Interventions Placebo oral capsule Saxagliptin 5mg ergometric test in healthy volunteers

Updated 4 times since 2019 Last updated: Apr 29, 2019 Started: Jun 5, 2018 Primary completion: Jul 18, 2018 Completion: Apr 15, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Physical Activity and Secretion; Catecholamine, this trial is completed. The trial is conducted by Eric Grouzmann and has accumulated 4 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jun 2019 — Jan 2021 [monthly]

Completed EARLY_PHASE1

First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eric Grouzmann
Nicolas Bourdillon
Philippe Eugster
grégoire millet
grégoire wuerzner

Data source: Centre Hospitalier Universitaire Vaudois

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lausanne, Switzerland